hello freinds this chart we shows that this market will know an uptrend on next days when i recommend buying with a fort probability if you have any questions you can write it in commentaire below and i will answer them and please don't forget to support this ideas with your like and comment thank you cordialy
RGLS continues pivoting around that 618 Fib line. Overall, it has held a clear uptrend despite the pullback. Trend line lines up almost perfectly with the latest higher lows put in. RNA companies remain a focus. In this case, it's not covid but kidney diseases. "In mid-May, Regulus Therapeutics announced an incremental update of its autosomal dominant...
The company's stock is in the consolidation stage strongly The stock is now buy I do not recommend Stop Loss because you will be taken out by the market makers I cannot say more details about my strategy as it is very confidential
Started buying in the handle, I feel breakout will happen next week. Price target on pattern 3.61. Overall price target is 5.00. There is bull flag forming on the handle.
Bullish Flag (47%) Pros: Volume during post formation Descending volume during Flag formation Golden cross in blue PPS above 50MA and 200MA RS above 0 R/R ratio above 3 200MA ascending Cons: RS flat ATR flat 250RSI below 50 and flat Target: PT = 2.73$ Help how ever you can to keep this alive. Thank you to those who have donated Coins! Always do your own due...
Entry price : 1.40 Fundamentals : - Sector: Medical - Biotech - EPS % Chg (Last Qtr): 85% - EPS % Chg (Previous Qtr): 22% - 3 Year EPS Growth Rate: 0% - EPS Est % Chg (Current Yr):0% - Sales % Chg (Last Qtr): 27678% - Sales % Chg (Previous Qtr): -% - 3-Year Sales Growth Rate: 196% - Annual Pre -Tax Margin: -272.1%
RGLS .. We are in full phase two COVID-19. There are many aspects and many pharmaceutical companies that are trying to shine, especially in the research and experimentation of drugs of all kinds ... Let's add that a Master of Biotech finance like Steven Cohen buys 8.5% of shares (5.6 million shares). .. Remember what happened to COCP when Cohen himself bought...
Pupm&Dump trading strategy idea. $RGLS is rising without clear preconditions today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $0,95; stop-loss — $1,08; take-profit — $0,92; Do not view this idea as a recommendation for trading or...
RGLS: Regulus Therapeutics Inc. 2020-07-29 08:07:00 Regulus Therapeutics Announces FDA Orphan Drug Designation of RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Regulus Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. RG-012 is an anti-miR targeting miR-21 in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326...
Possible break out soon. Low Risk / Reward to 50 dma Reason: Stair stepping on daily making higher lows Low volume Indicator: RSI is at 45 and has been increasing (not overbought yet) MACD still in negative so this might spike soon. Recent offering in 2018 had created a sell off and currently accumulation has been steadily moving the price higher. Higher...
It looks like a start of something big.
Possible pullback play here for a aggressive speculative setup. * Trade Criteria * Date First Found- January 10, 2018 Pattern/Why- Long from support; Speculative Pullback play Entry Target Criteria- Pull back to $1.10; Speculative entry at current price Exit Target Criteria- Momentum Stop Loss Criteria- N/A Special Note- Lots of insider buying Please check...